SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Autor: George Fountzilas, Takashi Fujii, Huifen Wang, Giovanni Melillo, Jun Zhang, Sara I. Pai, Loren Lipworth, Carlo Resteghini, Michael Stokes, Holger Mehlhorn, Asud Khaliq, Edward S. Kim, Nawar Shara, Philip Twumasi-Ankrah, Sophie Wildsmith, Norah J. Shire, Daniel R. Clayburgh, Neus Baste, Ezra E.W. Cohen, Derrick T. Lin

Publikováno v: Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Journal of Translational Medicine
Journal of translational medicine, vol 17, iss 1
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)

Biomarcador; Carcinoma de células escamosas de cabeza y cuello; PD-L1 Biomarker; Head and neck squamous cell carcinoma; PD-L1 Biomarcador; Carcinoma de cèl·lules escamoses de cap i coll; PD-L1 Background Programmed cell death ligand-1 (PD-L1) expr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a69b36b58079d706b0cc9b4d8420b6e
http://hdl.handle.net/11351/5875